[go: up one dir, main page]

DK1257829T3 - Komplementationsassay der vurderer proteinoplöselighed og -foldning - Google Patents

Komplementationsassay der vurderer proteinoplöselighed og -foldning

Info

Publication number
DK1257829T3
DK1257829T3 DK01909281T DK01909281T DK1257829T3 DK 1257829 T3 DK1257829 T3 DK 1257829T3 DK 01909281 T DK01909281 T DK 01909281T DK 01909281 T DK01909281 T DK 01909281T DK 1257829 T3 DK1257829 T3 DK 1257829T3
Authority
DK
Denmark
Prior art keywords
protein
folding
improper
marker protein
protein solubility
Prior art date
Application number
DK01909281T
Other languages
English (en)
Inventor
Philip Jordan Thomas
John F Hunt
William Christian Wigley
Rhesa D Stidham
Original Assignee
Univ Texas
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Univ Columbia filed Critical Univ Texas
Priority claimed from PCT/US2001/005097 external-priority patent/WO2001060840A2/en
Application granted granted Critical
Publication of DK1257829T3 publication Critical patent/DK1257829T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01909281T 2000-02-14 2001-02-14 Komplementationsassay der vurderer proteinoplöselighed og -foldning DK1257829T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18228300P 2000-02-14 2000-02-14
US09/775,051 US6727070B2 (en) 2000-02-14 2001-01-31 Protein/solubility folding assessed by structural complementation
PCT/US2001/005097 WO2001060840A2 (en) 2000-02-14 2001-02-14 Complementation assay assessing protein solubility and folding

Publications (1)

Publication Number Publication Date
DK1257829T3 true DK1257829T3 (da) 2007-02-12

Family

ID=56290109

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01909281T DK1257829T3 (da) 2000-02-14 2001-02-14 Komplementationsassay der vurderer proteinoplöselighed og -foldning

Country Status (9)

Country Link
US (3) US6727070B2 (da)
EP (1) EP1257829B1 (da)
JP (1) JP4772247B2 (da)
AT (1) ATE342510T1 (da)
AU (2) AU3705501A (da)
CA (1) CA2398834C (da)
DE (1) DE60123755T2 (da)
DK (1) DK1257829T3 (da)
ES (1) ES2273809T3 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727070B2 (en) * 2000-02-14 2004-04-27 The Board Of Regents, The University Of Texas System Protein/solubility folding assessed by structural complementation
US8609436B2 (en) * 2000-03-17 2013-12-17 Guy's & St Thomas' Hospital NHS Trust (“GST”) Method
US8088586B2 (en) * 2000-03-17 2012-01-03 Oxford Radcliffe Hospital Nhs Trust Method of producing a body fluid sample depleted of anti-MHC antibodies
US20040137480A1 (en) * 2001-08-30 2004-07-15 Eglen Richard M. Monitoring intracellular proteins
US20060105377A1 (en) * 2001-08-30 2006-05-18 Eglen Richard M Screening to optimize RNAi
EP2400030B1 (en) * 2004-05-18 2016-01-20 The Board of Trustees of the Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
CA2638888A1 (en) * 2004-12-04 2006-06-15 The Regents Of The University Of California Protein subcellular localization assays using split fluorescent proteins
EP1683868A1 (en) * 2005-01-21 2006-07-26 Medizinische Universität Graz Kringle domains in a calcium sensor fusion protein
CA2642911A1 (en) * 2005-02-22 2006-08-31 The Regents Of University Of California Circular permutant gfp insertion folding reporters
US7355920B2 (en) * 2006-02-16 2008-04-08 Micron Technology, Inc. Write latency tracking using a delay lock loop in a synchronous DRAM
JP5758801B2 (ja) 2008-07-22 2015-08-05 トラスティーズ・オブ・ダートマス・カレッジTrustees of Dartmouth College 単環式シアノエノンおよびその使用方法説明
DE102008048036A1 (de) * 2008-09-19 2010-03-25 Meurer, Heinrich, Dr. Verfahren zur Detektion ionisierender Strahlung
US8892184B2 (en) 2010-10-18 2014-11-18 Siemens Medical Solutions Usa, Inc. Systems and methods for reducing interference in a dual modality imaging system
WO2016100184A1 (en) 2014-12-16 2016-06-23 Forum Pharmaceuticals, Inc. Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
WO2016201096A1 (en) 2015-06-10 2016-12-15 Forum Pharmaceuticals, Inc. Aminobenzisoxazole compounds as agonists of a7-nicotinic acetylcholine receptors
WO2017027600A1 (en) 2015-08-12 2017-02-16 Forum Pharmaceuticals, Inc. GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120653A (en) 1985-04-08 1992-06-09 Microgenics Corporation Vector comprising DNA sequence coding for enzyme-donor polypeptide
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US6294330B1 (en) * 1997-01-31 2001-09-25 Odyssey Pharmaceuticals Inc. Protein fragment complementation assays for the detection of biological or drug interactions
US6342345B1 (en) 1997-04-02 2002-01-29 The Board Of Trustees Of The Leland Stanford Junior University Detection of molecular interactions by reporter subunit complementation
US6727070B2 (en) * 2000-02-14 2004-04-27 The Board Of Regents, The University Of Texas System Protein/solubility folding assessed by structural complementation

Also Published As

Publication number Publication date
US20070178498A1 (en) 2007-08-02
US6727070B2 (en) 2004-04-27
US7455978B2 (en) 2008-11-25
ES2273809T3 (es) 2007-05-16
EP1257829B1 (en) 2006-10-11
US7635569B2 (en) 2009-12-22
AU3705501A (en) 2001-08-27
CA2398834C (en) 2010-08-10
DE60123755T2 (de) 2007-10-18
EP1257829A2 (en) 2002-11-20
US20050019829A1 (en) 2005-01-27
JP4772247B2 (ja) 2011-09-14
AU2001237055B2 (en) 2006-09-14
US20040002065A1 (en) 2004-01-01
CA2398834A1 (en) 2001-08-23
JP2004500092A (ja) 2004-01-08
DE60123755D1 (de) 2006-11-23
ATE342510T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DK1257829T3 (da) Komplementationsassay der vurderer proteinoplöselighed og -foldning
DE69933661D1 (de) Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
EP0960939A3 (en) Dual-tagged proteins and their uses
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ES2109982T3 (es) Procedimiento y composiciones de ensayo para determinar proteasas en suero, particularmente proteina c activada.
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
CY1113124T1 (el) Μεθοδοι ανιχνευσης αλληλουχιων νουκλεϊκων οξεων σε ουρα
DE69222303D1 (de) Kationisierte antikörper gegen intrazelluläre eiweisse
SE9500023L (sv) Sätt att detektera cancer
NO920125L (no) Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fritt protein s eller protein c i en plasmaproeve
ATE392620T1 (de) Nachweismittel von patologischen veränderungen des proteins app und ihre verwendungen
ATE304052T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
WO2000009709A3 (en) Proteases and associated proteins
WO2001060840A3 (en) Complementation assay assessing protein solubility and folding
ATE207205T1 (de) Verfahren zumm assay von endotoxin-konzentration
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
HUP9800782A2 (hu) Új antitest, az azt tartalmazó renin-aktív anyag és a prorenin vizsgálatára szolgáló reagens
DE68929511D1 (de) Nachweis, Quantifizierung und Klassifizierung von RAS-Proteinen in Körperflüssigkeiten und Geweben
ATE247831T1 (de) Verfahren zum nachweis von autoimmun-pathologien
ATE267253T1 (de) Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung
WO1999038975A3 (en) Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof
FR2761697B1 (fr) Methodes de detection d'interactions entre plusieurs proteines
GB2289125A (en) Methods of assaying data-repairing enzymes and their alkylated derivatives